STOCK TITAN

[6-K] MESOBLAST LTD Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Mesoblast Limited furnished a Form 6-K noting that, on October 15, 2025, it filed several announcements with the Australian Securities Exchange. The report attaches and incorporates by reference four ASX documents: Appendix 3G (notification of issue, conversion or payment up of unquoted equity securities), Appendix 3H (notification of cessation of securities), Appendix 3Y (change of director’s interest notice), and Appendix 2A (application for quotation of securities).

The exhibits are labeled 99.1 through 99.4 and the report is signed by Company Secretary Niva Sivakumar.

Mesoblast Limited ha fornito un Form 6-K indicando che, il 15 ottobre 2025, ha presentato diversi comunicati alla Borsa australianà (ASX). Il rapporto allega e incorpora per riferimento quattro documenti ASX: Appendice 3G (nota di emissione, conversione o pagamento di titoli di capitale non quotati), Appendice 3H (nota di cessazione di titoli), Appendice 3Y (notifica di cambio di interesse del direttore) e Appendice 2A (domanda di quotazione dei titoli).

Gli allegati sono etichettati 99.1–99.4 e il rapporto è firmato dal Segretario della Società Niva Sivakumar.

Mesoblast Limited proporcionó un Formulario 6-K indicando que, el 15 de octubre de 2025, presentó varios comunicados ante la Bolsa de Valores de Australia (ASX). El informe adjunta e incorpora por referencia cuatro documentos de la ASX: Anexo 3G (notificación de emisión, conversión o pago de valores de capital no cotizados), Anexo 3H (notificación de cese de valores), Anexo 3Y (notificación de cambio de interés del director) y Anexo 2A (solicitud de cotización de valores).

Los anexos están etiquetados 99.1–99.4 y el informe está firmado por la Secretari­a de la Empresa Niva Sivakumar.

Mesoblast Limited는 2025년 10월 15일 호주 증권거래소(ASX)에 여러 공시를 제출했다고 밝힌 Form 6-K를 제출했다. 보고서는 ASX 문서 네 건을 참조로 첨부 및 포함한다: 부록 3G(비상장 주식의 발행, 전환 또는 지급 통지), 부록 3H(증권의 중단 통지), 부록 3Y(이사 이익 변경 통지), 부록 2A(증권 시세 표기 신청). 첨부 파일은 99.1~99.4로 표기되며 보고서는 회사 비서 Niva Sivakumar가 서명했다.

Mesoblast Limited a fourni un Formulaire 6-K indiquant que, le 15 octobre 2025, il a déposé plusieurs communiqués auprès de l'Australian Securities Exchange. Le rapport joint et incorpore par référence quatre documents ASX : Annexe 3G (notification d'émission, de conversion ou de paiement d'ordres sur des valeurs propres non cotées), Annexe 3H (notification de cessation de valeurs), Annexe 3Y (avis de changement d'intérêt du directeur) et Annexe 2A (demande de cotation des valeurs). Les pièces jointes portent les références 99.1 à 99.4 et le rapport est signé par le Secrétaire de l'entreprise Niva Sivakumar.

Mesoblast Limited hat ein Form 6-K vorgelegt und mitgeteilt, dass am 15. Oktober 2025 mehrere Ankündigungen bei der Australian Securities Exchange (ASX) eingereicht wurden. Der Bericht fügt vier ASX-Dokumente als Anlagen bei und verweist darauf: Anhang 3G (Mitteilung über Ausgabe, Wandel oder Zahlung ungekörter Eigenkapitalwerte), Anhang 3H (Mitteilung über Beendigung von Wertpapieren), Anhang 3Y (Mitteilung über Änderung der Interessen des Direktors) und Anhang 2A (Antrag auf Notierung von Wertpapieren). Die Exhibits tragen die Bezeichnungen 99.1 bis 99.4 und der Bericht ist vom Company Secretary Niva Sivakumar unterschrieben.

قدمت Mesoblast Limited نموذج 6-K يفيد بأنه، في 15 أكتوبر 2025، قد قدمت عدة إعلانات إلى بورصة الأوراق المالية الأسترالية (ASX). يفيد التقرير ويرفق بالإحالة أربعة وثائق ASX: الملحق 3G (إشعار الإصدار أو التحويل أو الدفع لأسهم رأس المال غير المدرجة)، الملحق 3H (إشعار إنهاء الأوراق المالية)، الملحق 3Y (إشعار تغيير مصلحة المدير)، والملحق 2A (طلب اقتباس الأوراق المالية). المرفقات بعنوان 99.1 حتى 99.4 وتوقيع التقرير من قبل أمين سر الشركة Niva Sivakumar.

Mesoblast Limited 提供了一份 Form 6-K,指出其于 2025 年 10 月 15 日向澳大利亚证券交易所(ASX)提交了若干公告。该报告附带并通过引用引用四份 ASX 文件:附录 3G(未在交易所上市的股权证券的发行、转换或付款通知)、附录 3H(证券停止通知)、附录 3Y(董事权益变动通知)以及附录 2A(证券报价申请)。附件标记为 99.1 至 99.4,报告由公司秘书 Niva Sivakumar 签署。

Positive
  • None.
Negative
  • None.

Mesoblast Limited ha fornito un Form 6-K indicando che, il 15 ottobre 2025, ha presentato diversi comunicati alla Borsa australianà (ASX). Il rapporto allega e incorpora per riferimento quattro documenti ASX: Appendice 3G (nota di emissione, conversione o pagamento di titoli di capitale non quotati), Appendice 3H (nota di cessazione di titoli), Appendice 3Y (notifica di cambio di interesse del direttore) e Appendice 2A (domanda di quotazione dei titoli).

Gli allegati sono etichettati 99.1–99.4 e il rapporto è firmato dal Segretario della Società Niva Sivakumar.

Mesoblast Limited proporcionó un Formulario 6-K indicando que, el 15 de octubre de 2025, presentó varios comunicados ante la Bolsa de Valores de Australia (ASX). El informe adjunta e incorpora por referencia cuatro documentos de la ASX: Anexo 3G (notificación de emisión, conversión o pago de valores de capital no cotizados), Anexo 3H (notificación de cese de valores), Anexo 3Y (notificación de cambio de interés del director) y Anexo 2A (solicitud de cotización de valores).

Los anexos están etiquetados 99.1–99.4 y el informe está firmado por la Secretari­a de la Empresa Niva Sivakumar.

Mesoblast Limited는 2025년 10월 15일 호주 증권거래소(ASX)에 여러 공시를 제출했다고 밝힌 Form 6-K를 제출했다. 보고서는 ASX 문서 네 건을 참조로 첨부 및 포함한다: 부록 3G(비상장 주식의 발행, 전환 또는 지급 통지), 부록 3H(증권의 중단 통지), 부록 3Y(이사 이익 변경 통지), 부록 2A(증권 시세 표기 신청). 첨부 파일은 99.1~99.4로 표기되며 보고서는 회사 비서 Niva Sivakumar가 서명했다.

Mesoblast Limited a fourni un Formulaire 6-K indiquant que, le 15 octobre 2025, il a déposé plusieurs communiqués auprès de l'Australian Securities Exchange. Le rapport joint et incorpore par référence quatre documents ASX : Annexe 3G (notification d'émission, de conversion ou de paiement d'ordres sur des valeurs propres non cotées), Annexe 3H (notification de cessation de valeurs), Annexe 3Y (avis de changement d'intérêt du directeur) et Annexe 2A (demande de cotation des valeurs). Les pièces jointes portent les références 99.1 à 99.4 et le rapport est signé par le Secrétaire de l'entreprise Niva Sivakumar.

Mesoblast Limited hat ein Form 6-K vorgelegt und mitgeteilt, dass am 15. Oktober 2025 mehrere Ankündigungen bei der Australian Securities Exchange (ASX) eingereicht wurden. Der Bericht fügt vier ASX-Dokumente als Anlagen bei und verweist darauf: Anhang 3G (Mitteilung über Ausgabe, Wandel oder Zahlung ungekörter Eigenkapitalwerte), Anhang 3H (Mitteilung über Beendigung von Wertpapieren), Anhang 3Y (Mitteilung über Änderung der Interessen des Direktors) und Anhang 2A (Antrag auf Notierung von Wertpapieren). Die Exhibits tragen die Bezeichnungen 99.1 bis 99.4 und der Bericht ist vom Company Secretary Niva Sivakumar unterschrieben.


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
For the month of October 2025
Commission File Number 001-37626
Mesoblast Limited
(Exact name of Registrant as specified in its charter)
Not Applicable
(Translation of Registrant’s name into English)
Australia
(
Jurisdiction of incorporation or organization)

Silviu Itescu
Chief Executive Officer and Executive Director
Level 38
55 Collins Street
Melbourne 3000
Australia
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:
Form 20-F Form 40-F





INFORMATION CONTAINED ON THIS REPORT ON FORM 6-K
On October 15, 2025, Mesoblast Limited filed with the Australian Securities Exchange a new issue announcement, notification of issue, conversion or payment up of unquoted equity securities (Appendix 3G) which is attached hereto as Exhibit 99.1, and is incorporated herein by reference.

On October 15, 2025, Mesoblast Limited filed with the Australian Securities Exchange a new issue announcement, notification of cessation of securities (Appendix 3H) which is attached hereto as Exhibit 99.2, and is incorporated herein by reference.

On October 15, 2025, Mesoblast Limited filed with the Australian Securities Exchange a new issue announcement, change of director’s interest notice (Appendix 3Y) which is attached hereto as Exhibit 99.3, and is incorporated herein by reference.
On October 15, 2025, Mesoblast Limited filed with the Australian Securities Exchange a new issue announcement, application for quotation of securities (Appendix 2A) which is attached hereto as Exhibit 99.4, and is incorporated herein by reference.




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized.

Mesoblast Limited
/s/ Niva Sivakumar
Niva Sivakumar
Company Secretary
Dated: October 15, 2025



INDEX TO EXHIBITS
Item
 99.1
Appendix 3G of Mesoblast Ltd, dated October 15, 2025.
 99.2
Appendix 3H of Mesoblast Ltd, dated October 15, 2025.
 99.3
Appendix 3Y of Mesoblast Ltd, dated October 15, 2025.
 99.4
Appendix 2A of Mesoblast Ltd, dated October 15, 2025.




FAQ

What did Mesoblast (MEOBF) report in its Form 6-K?

The company noted ASX filings dated October 15, 2025, and attached Appendix 3G, Appendix 3H, Appendix 3Y, and Appendix 2A as exhibits.

Which exhibits are included with Mesoblast’s (MEOBF) 6-K?

Exhibit 99.1: Appendix 3G; Exhibit 99.2: Appendix 3H; Exhibit 99.3: Appendix 3Y; Exhibit 99.4: Appendix 2A.

When were the ASX appendices filed by Mesoblast (MEOBF)?

They were filed on October 15, 2025, and are incorporated by reference in the 6-K.

Who signed Mesoblast’s (MEOBF) Form 6-K?

The report was signed by Company Secretary Niva Sivakumar.

What types of ASX notices did Mesoblast (MEOBF) attach?

A notification of new/unquoted equity securities (Appendix 3G), cessation of securities (Appendix 3H), change of director’s interest (Appendix 3Y), and application for quotation (Appendix 2A).
Mesoblast

OTC:MEOBF

MEOBF Rankings

MEOBF Latest SEC Filings

MEOBF Stock Data

902.81M